Literature DB >> 8391070

Preservation of olfaction in anterior craniofacial approaches.

R F Spetzler1, J M Herman, S Beals, E Joganic, J Milligan.   

Abstract

Through the combined efforts of neurosurgeons, head and neck surgeons, and craniofacial surgeons, the standard transbasal approach to the frontal fossa has been modified to include removal of the orbital roofs, nasion, and ethmoid sinuses. This approach has been combined further with facial disassembly procedures to provide extensive midline exposure to the midface and clival region. Extended frontal approaches, however, necessitate removal of the crista galli and sectioning of the olfactory rootlets with the associated risk of anosmia, cerebrospinal fluid (CSF) leak, and the need for complex reconstruction of the frontal floor. To avoid these problems, the authors have modified the technique of handling the cribriform plate to preserve the olfactory unit. Circumferential osteotomy cuts are made around the cribriform plate to allow an en bloc removal with its attachment to both the dura and underlying mucosa. Opening of the dura is avoided and the cribriform bone is used to reconstruct the floor. Four patients underwent this approach, for treatment of an angiofibroma in three and a fibrosarcoma in one. The mean follow-up period was 7 months. No patients developed a CSF leak, and within 8 weeks olfaction had returned in all patients. There was no other associated morbidity. These data suggest that this modification of the transbasilar approach can alleviate extensive reconstructive procedures and CSF leaks while preserving olfaction.

Entities:  

Mesh:

Year:  1993        PMID: 8391070     DOI: 10.3171/jns.1993.79.1.0048

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Intraoperative transillumination to determine the extent of frontal sinus in subcranial approach to anterior skull base.

Authors:  Rajeev Sharan; Krishnakumar Thankappan; Subramania Iyer; Dilip Panicker; Moni Abraham Kuriakose
Journal:  Skull Base       Date:  2011-03

2.  Quantification of the advantages of the extended frontal approach to skull base.

Authors:  Rajesh Acharya; Mark Shaya; Ravi Kumar; Gloria C Caldito; Anil Nanda
Journal:  Skull Base       Date:  2004-08

3.  Advances in surgical management of malignancies of the cranial base: the extended transbasal approach.

Authors:  James P Chandler; Harold J Pelzer; Bernard B Bendok; H Hunt Batjer; Sean A Salehi
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

4.  Extended transbasal approach: anatomy, technique, and indications.

Authors:  S Terasaka; J D Day; T Fukushima
Journal:  Skull Base Surg       Date:  1999

5.  Craniofacial resection: decreased complication rate with a modified subcranial approach.

Authors:  D A Ross; L J Marentette; C E Moore; K L Switz
Journal:  Skull Base Surg       Date:  1999

6.  Combined craniofacial resection of anterior skull base tumors: long-term results and experience of single institution.

Authors:  Bashar Abuzayed; Bulent Canbaz; Galip Zihni Sanus; Seckin Aydin; Harun Cansiz
Journal:  Neurosurg Rev       Date:  2010-09-29       Impact factor: 3.042

7.  Recovery of olfactory function after an anterior craniofacial approach.

Authors:  K Saito; M Takahashi; K Fukuta; E Tachibana; J Yoshida
Journal:  Skull Base Surg       Date:  1999

8.  Return of olfaction after gross total resection of an olfactory groove meningioma: case report.

Authors:  M Gerber; A G Vishteh; R F Spetzler
Journal:  Skull Base Surg       Date:  1998

9.  Proposed classification for the transbasal approach and its modifications.

Authors:  Iman Feiz-Erfan; Robert F Spetzler; Eric M Horn; Randall W Porter; Stephen P Beals; Salvatore C Lettieri; Edward F Joganic; Franco Demonte
Journal:  Skull Base       Date:  2008-01

10.  Transbasal approaches: surgical details, pitfalls and avoidances.

Authors:  Ali Kurtsoy; Ahmet Menku; Bulent Tucer; I Suat Oktem; Hidayet Akdemir; R Kemal Koc
Journal:  Neurosurg Rev       Date:  2004-04-08       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.